SELECT * FROM `tbl_content` WHERE `c_type` = 'advertise' AND `c_status` = '1' AND `c_is_deleted` = '0' ORDER BY `c_order` desc LIMIT 3 Association of Biotechnology Led Enterprises


Viela Bio, Mitsubishi Tanabe to co-develop, commercialize autoimmune disease drug in Japan and nine Asia regions

Mitsubishi Tanabe will lead the development and commercialization of inebilizumab in Japan, Thailand, South Korea, Indonesia, Vietnam, Malaysia, Philippines, Singapore, and Taiwan.

Oct 09, 2019

By : By Team ABLE

18% GST on biotech research services removed

Bangalore, 21 September 2018: The government has removed the 18% GST ( goods and services tax) levied on research services provided to foreign companies by biotech companies based in India. This was a major un-competitive factor making Indian biotech services uncompetitive. ABLE has been championing the need for this exemption for the last 18 months.

Sep 21, 2019

By : Narayanan Suresh

ABLE suggests key changes in ICMR gene therapy guidelines

While welcoming the comprehensive Draft Guidelines for Gene Therapy Product Development and Clinical Trials announced by the Indian Council of Medical Research (ICMR), the Association of Biotechnology Led Enterprises(ABLE) has suggested some key changes to be incorporated in the final guidelines.

Sep 18, 2019

By : Team ABLE

Biocon licenses three generic formulation products to China Medical System Holdings

This development is in line with Biocon’s long term generic formulations strategy and expands its Generic Formulations business footprint to the Chinese pharmaceuticals market.

Sep 16, 2019

By : Team ABLE

India joins the Global Antimicrobial Resistance Research and Development Hub

India has joined the Global Antimicrobial Resistance (AMR) Research and Development (R&D) Hub as a new member. This was announced On September 12thby the Department of Biotechnology, Ministry of Science & Technology in New Delhi.

Sep 13, 2019

By : Team ABLE